Publications by authors named "Sandra Dabora"

Claim this Profile
S
Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosis.
Izabela A Malinowska, Nancy Lee, Vidhya Kumar, Elizabeth A Thiele, David Neal Franz, Sandra L Dabora

PLoS One· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.
Sandra L Dabora, David Neal Franz, Stephen Ashwal, Arthur Sagalowsky, Francis J DiMario

PLoS One· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tsc2-Rheb signaling regulates EphA-mediated axon guidance.
Duyu Nie, Alessia Di Nardo, Juliette M Han, Hasani Baharanyi, Ioannis Kramvis, Sandra Dabora

Nat Neurosci· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.
Chelsey Woodrum, Alison Nobil, Sandra L Dabora

J Transl Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
Nancy Lee, Chelsey L Woodrum, Alison M Nobil, Aubrey E Rauktys, Michael P Messina, Sandra L Dabora

BMC Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model.
Aubrey Rauktys, Nancy Lee, Laifong Lee, Sandra L Dabora

BMC Dermatol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779.
Michael P Messina, Aubrey Rauktys, Laifong Lee, Sandra L Dabora

BMC Pharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma.
Daniel Cho, Sabina Signoretti, Sandra Dabora, Meredith Regan, Apryle Seeley

Clin Genitourin Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations.
Piotr Kozlowski, Penelope Roberts, Sandra Dabora, David Franz, John Bissler

Hum Genet· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.
Hongbing Zhang, Natalia Bajraszewski, Erxi Wu, Hongwei Wang, Annie P Moseman, Sandra L Dabora

J Clin Invest· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.
Laifong Lee, Paul Sudentas, Sandra L Dabora

Genes Chromosomes Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.
Laifong Lee, Paul Sudentas, Brian Donohue, Kirsten Asrican, Aelaf Worku, Sandra L Dabora

Genes Chromosomes Cancer· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 34 bp deletion within TSC2 is a rare polymorphism, not a pathogenic mutation.
Penelope S Roberts, Vijaya Ramesh, Sandra Dabora, David J Kwiatkowski

Ann Hum Genet· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients.
Sandra L Dabora, Penelope Roberts, Andres Nieto, Ron Perez, Sergiusz Jozwiak

Am J Hum Genet· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNP identification, haplotype analysis, and parental origin of mutations in TSC2.
Penelope S Roberts, Joon Chung, Sergiusz Jozwiak, Sandra L Dabora, David N Franz

Hum Genet· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis.
Francis McCormack, Alan Brody, Christopher Meyer, Jennifer Leonard, Gail Chuck, Sandra Dabora

Chest· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis